mdlinx mdlinx
Latest (358) Full Text Articles (5583) Article Summary

New Oral Anticoagulants: Benefit-Risk Profile, Recurrence Rates, and Long-term Complications in Patients Treated for Established VTE
Clinical Pulmonary Medicine,  Clinical Article

Tapson V – New oral anticoagulants that do not require injections, routine coagulation monitoring, dose adjustment, or food restrictions are currently in development and/or recently approved and may enable physicians to better control anticoagulation therapy. Several Phase III trials have reported that the direct Factor Xa inhibitors rivaroxaban and apixaban and the direct thrombin inhibitor dabigatran are as effective as or superior to currently used low–molecular weight heparins or vitamin K antagonists.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Nursing

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nursing Articles

Last month's top read Top Articles of 2013

Indexed Journals in Nursing: Journal of Advanced Nursing, Journal of Clinical Nursing, Nurse Education In Practicemore

Other Topics in Nursing

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close